北京大学肿瘤医院

返回

顶部

网站导航

肝胆胰外二科/软组织与腹膜后肿瘤中心 - 刘伯南

刘伯南简介

刘伯南医生本科毕业于北京大学医学部,随后在北京协和医学院北京协和医院进行了严格的外科训练,获外科学博士学位。训练期间,他对肿瘤外科产生了浓厚的兴趣。此后他在北京大学肿瘤医院圆满完成了肿瘤外科专科医生培训。目前他担任肝胆胰外科二病区/腹膜后软组织肿瘤科副主任医师,擅长腹部肿瘤,尤其是肝胆胰肿瘤、腹膜后肿瘤以及复杂胃肠道肿瘤的诊断和外科治疗,并积极参加相关专业领域多学科协作。近年来,他还参与完成了北京市首发科研专项和医管局登峰计划等项目,并在国内外期刊发表了多篇学术论文,既是总结经验,亦是开拓创新。他以患者为中心,提供规范、前沿以及个体化的诊疗服务,同时也为患者提供多种诊疗方案,丰富患者的治疗选择。

发表论文

近3年发表的文章(按时间顺序)

• Xue G, Wang X, Liu B, et al. Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis. J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343.

• Xue G, Wang Z, Liu B, et al. Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis. Int J Clin Oncol. 2024 Jul;29(7):1035-1043.

• Qiu H, Wang Z, Liu B, et al. Surgical outcomes of locally advanced gastrointestinal stromal tumors after multivisceral resection: A retrospective study of 64 patients at a single institution. Intractable Rare Dis Res. 2024 Feb;13(1):51-56.

• Wu J, Li C, Liu B, et al. Efficacy and safety of anlotinib plus camrelizumab in treating retroperitoneal soft tissue sarcomas: a single-center retrospective cohort study. Ann Transl Med. 2023 Mar 15;11(5):212.

• Lv A, Liu BN, Liu DN, et al. Abdominoinguinal approach in en bloc resection of retroperitoneal sarcoma involving iliac vessels with graft interposition. Front Oncol. 2022 Dec 23;12:1040833.

• Shi YJ #, Liu BN #, Li XT, et al. Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2022 Sep;47(9):3217-3228. # 共同第一作者

• Li CP, Liu BN, Wu JH, et al. Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery. Updates Surg. 2022 Jun;74(3):1157-1163.

• Liu B, Wu J, Li C, et al. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor? Pancreatology. 2022 Jan;22(1):112-122.